5. Definition
⢠Meningitis: Inflammation of leptomeninges ( pia and arachnoid mater)
with or without suppuration of csf
⢠Encephalitis: Inflammation of brain parenchyma
6. ⢠Acute meningitis presents with triad of pyrexia, headache and meningism
(headache, photophobia, stiffness of neck and other signs)
⢠The severity of clinical features varies with the causative organism,
as does the presence of other features such as a rash
⢠Abnormalities in the CSF are important in distinguishing the cause of
meningitis.
8. o Non-infective (âsterileâ)
ďą Malignant disease
⢠Breast cancer
⢠Bronchial cancer
⢠Leukaemia
⢠Lymphoma
ďą Inflammatory disease (may be recurrent)
⢠Sarcoidosis
⢠SLE
⢠Behçetâs disease
ďą Protozoa and parasites
⢠Cysticerci ⢠Amoeba
ďą Fungi
⢠Cryptococcus neoformans ⢠Candida â˘Histoplasma
⢠Blastomyces ⢠Coccidioides ⢠Sporothrix
9.
10. Viral meningitis
⢠Viruses, most common cause of meningitis,usually resulting in a
benign and self-limiting illness
⢠Requires no specific therapy and much less serious than bacterial
unless encephalitis
⢠Occurs mainly in children or young adults, with acute headache (most
severe), irritability and rapid development of meningism
⢠There may be a high pyrexia but focal neurological signs are rare
11. ⢠CSF: excess of lymphocytes with normal glucose and protein levels?
⢠Prior antibiotic?
⢠Usually benign and self-limiting
⢠Should be treated symptomatically and recovers within days, although
a lymphocytic pleocytosis may persist in the CSF
⢠Meningitis can be complication of a systemic viral infection such as
mumps, measles, infectious mononucleosis, herpes zoster and hepatitis
12. Bacterial Meningitis
⢠Usually part of a bacteraemic illness, although direct spread from an
adjacent focus of infection in the ear, skull fracture or sinus
⢠Early diagnosis and the prompt initiation of therapy determines prognosis
⢠Epidemics of meningococcal meningitis occur particularly in cramped
living conditions/ hot and dry climate
⢠The organism invades through the nasopharynx, producing septicaemia and
meningitis
13. Pathophysiology
⢠Infection stimulates immune response, meninges: congested and
infiltrated with inflammatory cells
⢠Then pus forms in layers, may later organise to form adhesions
obstructing the flow of CSF, leading to hydrocephalus, or damage the
cranial nerves at bases
⢠Hearing loss is a frequent
14. Clinical features
⢠Headache, drowsiness, fever and neck stiffness
⢠In severe: coma and later may be focal neurological signs
⢠Ninety percent with meningococcal meningitis will have two : fever,
neck stiffness, altered consciousness and rash
⢠When accompanied by septicaemia, it may present very rapidly, with
abrupt onset of obtundation due to cerebral oedema
15. ⢠Chronic meningococcaemia is a rare condition in which the patient can be
unwell for weeks or even months with recurrent fever, sweating, joint pains
and transient rash usually occurs in splenectomised
⢠In pneumococcal and Haemophilus infections there may be an associated
otitis media
⢠Pneumococcal meningitis may be associated with pneumonia and occurs
especially in older patients and alcoholics, as well as those without
functioning spleens.
⢠Listeria monocytogenes is an increasing cause of meningitis in the
immunosuppressed, diabetics, alcoholics and pregnant women
16. Investigations
⢠Lumbar puncture is mandatory unless contraindicated (drowsy, focal neurological
signs, seizures, immunosuppressed, recent neurosurgery or head injury) ? CT
⢠If deferred or omitted, take blood cultures and start empirical treatment
⢠Lumbar puncture will help differentiate the causative organism: in bacterial meningitis
the CSF is cloudy (turbid) due to the presence of many neutrophils (often > 1000 Ă 10
cells/L), the protein content is significantly elevated and the glucose reduced
⢠Gram film and culture may allow identification of the organism
⢠PCR techniques can be used; useful in detecting meningococcal infection and in typing
the organism
17.
18.
19. Management
⢠Untreated mortality rate of around 80%, so swift
⢠If bacterial meningitis is suspected, parenteral benzylpenicillin
immediately (intravenous is preferable) and prompt hospital admission
should be arranged
⢠Adjunctive corticosteroid therapy is useful in both children and adults
in developed countries where the incidence of penicillin resistance is
low,
⢠In meningococcal disease, mortality is doubled if the patient presents
with features of septicaemia rather than meningitis
20.
21.
22. ⢠Intensive care facilities: with cardiac, respiratory or renal involvement, and
CNS depression
⢠Early endotracheal intubation and mechanical ventilation protect the
airway and may prevent the development of the acute respiratory distress
syndrome
⢠Adverse prognostic features: hypotensive shock, a rapidly developing rash,
a haemorrhagic diathesis, multisystem failure and age over 60 years
23. Prevention of meningococcal
⢠Close contacts of patients with meningococcal infection should be given 2 days of
oral rifampicin
⢠In adults, a single dose of ciprofloxacin is an alternative
⢠If not treated with ceftriaxone, the index case should be given similar treatment to
clear infection from the nasopharynx before hospital discharge
⢠Vaccines are available for most meningococcal subgroups but not group B, which is
among the most common serogroup isolated in many countries
24.
25. Tuberculous meningitis
⢠Common in developing countries and is seen more frequently as a
secondary infection in patients with AIDS
⢠Tuberculous meningitis most commonly occurs shortly after a primary
infection in childhood or as part of miliary tuberculosis
⢠Usual local source of infection is a caseous focus in the meninges or brain
substance adjacent to the CSF pathway
⢠Brain is covered by a greenish, gelatinous exudate, especially around the
base, and numerous scattered tubercles are found on the meninges
26. Clinical features
⢠Onset is slower than in other bacterial meningitis: 2â8 weeks
⢠If untreated, fatal in a few weeks but complete recovery is usual if
treatment is started at stage I
⢠When treatment is initiated later, the rate of death or serious
neurological deficit may be as high as 30%.
27.
28. Investigations
⢠CSF is under increased pressure, usually clear but, a fine clot strand (âspider webâ) on
standing
⢠Contains up to 500 à 106 /L, predominantly lymphocytes, but can contain neutrophils
⢠There is a rise in protein and a marked fall in glucose
⢠The tubercle bacillus may be detected in a smear of the centrifuged deposit from the CSF but
a negative result does not exclude the diagnosis
⢠The CSF should be cultured but, as this result will not be known for up to 6 weeks, treatment
must be started without waiting for confirmation
⢠Brain imaging may show hydrocephalus, brisk meningeal enhancement or tuberculoma
29. Management
⢠As soon as the diagnosis is made or strongly suspected, chemotherapy should be
started
⢠2HRZE plus 7HRE (12months of treatment)
⢠Corticosteroids improves mortality, if given early but not focal neurological
damage
⢠Surgical ventricular drainage may be needed if obstructive hydrocephalus
develops
⢠Skilled nursing is essential during the acute phase of the illness, and adequate
hydration and nutrition must be maintained
30. ⢠Fungal meningitis: Usually occurs in patients who are immunosuppressed
and is a recognised complication of HIV infection
⢠CSF findings are similar to those of tuberculous meningitis, but the
diagnosis can be confirmed by microscopy or specific serological tests
⢠In some areas, meningitis may be caused by spirochaetes (leptospirosis,
Lyme disease and syphilis â rickettsiae (typhus fever) or protozoa
(amoebiasis ).
31. ⢠Meningitis can also be due to non-infective pathologies
⢠This is seen in recurrent aseptic meningitis due to SLE, Behçetâs
disease or sarcoidosis, as well as a condition of previously unknown
origin known as Mollaretâs syndrome, in which the recurrent
meningitis is associated with epithelioid cells in the spinal fluid
(âMollaretâcells)
⢠Recent evidence suggests that this condition may be due to human
herpes virus type 2, and is therefore infective after all
⢠Meningitis can also be seen due to neoplastic cells
32. Viral encephalitis
⢠In Europe, the most serious herpes simplex which probably reaches the brain via the
olfactory nerves
⢠Varicella zoster is also an important cause
⢠Development of effective therapy for some forms of encephalitis has increased the
importance of clinical diagnosis and virological examination of the CSF
⢠In some parts of the world, viruses transmitted by mosquitoes and ticks (arboviruses)
are an important cause of encephalitis
⢠Japanese encephalitis has spread relentlessly across Asia to Australia, and there have
been outbreaks of West Nile encephalitis in Romania, Israel and New York
⢠HIV may cause encephalitis with a subacute or chronic presentation
33. Pathophysiology
⢠The infection provokes an inflammatory response involves the cortex,
white matter, basal ganglia and brainstem
⢠HSV: temporal lobes; Cytomegalovirus: areas adjacent to ventricles
⢠Inclusion bodies infiltration of polymorphonuclear cells in the
perivascular space
⢠Neuronal degeneration and diffuse glial proliferation, often associated
with cerebral oedema
34. Clinical features
⢠Headache, fever, focal neurological signs (aphasia and/orhemiplegia,
visual field defects) and seizures
⢠Disturbance of consciousness ranging from drowsiness to deep coma
supervenes early and may advance dramatically
⢠Meningism occurs in many patients
35. Investigations
⢠CT scan: low-density lesions in the temporal lobes but MRI is more sensitive
⢠CSF contains lymphocytes but polymorphonuclear cells may predominate in the early
stages, may be normal in up to 10% of cases
⢠West Nile virus, may have sustained neutrophilic CSF
⢠The protein content may be elevated but the glucose is normal
⢠The EEG is usually abnormal in the early stages, especially in herpes simplex:
periodic slow-wave activity in the temporal lobes
⢠Virological investigations of the CSF, including PCR for viral DNA, may reveal the
causative organism but treatment initiation should not await this.
36. Management
⢠Aciclovir 10 mg/kg IV 3 times daily for 2â3 weeks reduced mortality from
70% to 10%
⢠This should be given early to all patients suspected of suffering from viral
encephalitis
⢠Some survivors will have residual epilepsy or cognitive impairment
⢠Anticonvulsant treatment may be needed and raised intracranial pressure
may indicate the need for dexamethasone.
37. Brainstem encephalitis
⢠This presents with ataxia, dysarthria, diplopia or other cranial nerve
palsies
⢠CSF is lymphocytic, with normal glucose
⢠The causative agent is presumed to be viral
⢠However, Listeria monocytogenes may cause a similar syndrome with
meningitis (and often a polymorphonuclear CSF pleocytosis) and
requires specific treatment with ampicillin
38. Rabies
⢠Rhabdovirus that infects the central nervous tissue and salivary glands of a wide
range of mammals, and is usually conveyed by saliva through bites or licks on
abrasions or on intact mucous membranes
⢠Humans are most frequently infected from dogs and bats
⢠Incubation period minimum of 9 days to many months but is usually between 4
and 8 weeks
⢠Severe bites, especially on the head or neck, shorter incubation periods
⢠Human rabies is a rare disease, even in endemic areas
39. Clinical features
⢠At onset; fever, and paraesthesia at the site of the bite
⢠A prodromal period of 1â10 days, during which the patient becomes increasingly anxious, leads
to the characteristic âhydrophobiaâ
⢠Although the patient is thirsty, attempts at drinking provoke violent contractions of the
diaphragm and other inspiratory muscles
⢠Delusions and hallucinations may develop, accompanied by spitting, biting and mania, with lucid
intervals in which the patient is markedly anxious
⢠Cranial nerve lesions develop and terminal hyperpyrexia is common
⢠Death ensues, usually within a week of the onset of symptoms
40. Investigations
⢠During life, the diagnosis is usually made on clinical grounds but rapid
immunofluorescent techniques can detect antigen in corneal
impression smears or skin biopsies
41. Management
⢠Established disease: Only a few have survived
⢠All received some post-exposure prophylaxis and needed intensive care facilities
to control cardiac and respiratory failure
⢠Otherwise, only palliative treatment is possible once symptoms have appeared
⢠The patient should be heavily sedated with diazepam, supplemented by
chlorpromazine if needed
⢠Nutrition and fluids should be given intravenously or through a gastrostomy.
42. Pre-exposure prophylaxis
⢠Intradermal injections of human diploid cell strain vaccine, or two
intramuscular injections given 4 weeks apart, followed by yearly
boosters
43. Post-exposure prophylaxis
⢠The wounds should be thoroughly cleaned, preferably with a quaternary
ammonium detergent or soap; damaged tissues should be excised and the
wound left unsutured
⢠Rabies can usually be prevented if treatment is started within a day or two of
biting
⢠For maximum protection, hyperimmune serum and vaccine are required
⢠The safest antirabies antiserum is human rabies immunoglobulin
⢠The dose is 20 U/kg body weight; half is infiltrated around the bite and half is
given intramuscularly at a different site from the vaccine
44. ⢠Human diploid cell strain vaccine; 1.0 mL is given intramuscularly on
days 0, 3, 7, 14, 30 and 90
⢠In developing countries, 0.1 mL of vaccine may be given intradermally
into eight sites on day 1, with single boosters on days 7 and 28
45. Poliomyelitis
⢠Subgroup of the enteroviruses
⢠Problem in the developing world, especially parts of Africa
⢠Infection usually occurs through the nasopharynx
⢠The virus causes a lymphocytic meningitis and infects the grey matter of the
spinal cord, brainstem and cortex
⢠There is a particular propensity to damage anterior horn cells, especially in
the lumbar segments
46. Clinical features
⢠Incubation period: 7â14 days
⢠Many patients recover fully after the initial phase of a few days of mild fever and
headache
⢠In other individuals, after a week of well-being, there is a recurrence of pyrexia,
headache and meningism
⢠Weakness may start later in one muscle group and can progress to widespread paresis
⢠Respiratory failure may supervene if intercostal muscles are paralysed or the medullary
motor nuclei are involved
47. ⢠Epidemics vary widely in terms of the incidence of nonparalytic cases and in
mortality rate
⢠Death occurs from respiratory paralysis
⢠Muscle weakness is maximal at the end of the first week and gradual recovery
may then take place over several months
⢠Muscles showing no signs of recovery after a month will probably not regain
useful function
⢠Second attacks are very rare but occasionally patients show late deterioration in
muscle bulk and power many years after the initial infection (this is termed the
âpost-polio syndromeâ).
48.
49. Investigations
⢠CSF: lymphocytic pleocytosis, a rise in protein and a normal sugar content
⢠Cultured from CSF and stool
Management
Established disease:
⢠In the early stages, bed rest is imperative because exercise worsen the
paralysis
⢠Onset of respiratory difficulties, a tracheostomy and ventilation are required
⢠Subsequent treatment is by physiotherapy and orthopaedic measures.
50. Prophylaxis
⢠Prevention of poliomyelitis is by immunisation with live (Sabin) vaccine
⢠In developed countries where it is rare live vaccine
51. Herpes zoster (shingles)
⢠Reactivation of the varicella zoster virus that has lain dormant in a
nerve root ganglion following chickenpox earlier in life
⢠Reactivation may be spontaneous (as usually occurs in the middle
aged or elderly) or due to immunosuppression (as in patients with
diabetes, malignant disease or AIDS)
52. Subacute sclerosing
panencephalitis
⢠Rare, chronic, progressive and eventually fatal complication of
measles, presumably a result of an inability of the nervous system to
eradicate the virus
⢠Occurs in children and adolescents, many years after the primary virus
infection
⢠There is generalised neurological deterioration and onset is insidious,
with intellectual deterioration, apathy and clumsiness, followed by
myoclonic jerks, rigidity and dementia
53. ⢠CSF: mild lymphocytic pleocytosis
⢠EEG: characteristic periodic bursts of triphasic waves
⢠Although there is persistent measles specific IgG in serum and CSF,
antiviral therapy is ineffective and death ensues within a few years
54. Progressive multifocal
leucoencephalopathy
⢠Originally described as a rare complication of lymphoma, leukaemia or carcinomatosis,
but has become more frequent as a feature of AIDS
⢠Infection of oligodendrocytes by human polyomavirus JC, which causes widespread
demyelination of the white matter of the cerebral hemispheres
⢠Clinical signs include dementia, hemiparesis and aphasia, which progress rapidly, usually
leading to death within weeks or months
⢠Areas of low density in the white matter are seen on CT but MRI is more sensitive,
showing diffuse high signal in the cerebral white matter on T2-weighted images
⢠Only treatment available is to restore the immune response (by treating AIDS or any
other cause of immunosuppression).